{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:35:34Z","timestamp":1761514534247},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00108-020-00757-5","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T16:20:49Z","timestamp":1582042849000},"page":"326-332","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Moderne Migr\u00e4netherapie \u2013 fach\u00fcbergreifende Versorgung im Langzeitverlauf"],"prefix":"10.1007","volume":"61","author":[{"given":"Hartmut","family":"G\u00f6bel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Heinze-Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl H. H.","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"757_CR1","volume-title":"Atlas of headache disorders and resources in the world","author":"World Health Organization","year":"2011","unstructured":"World Health Organization (2011) Atlas of headache disorders and resources in the world"},{"issue":"1","key":"757_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner\u00a0TJ, Stovner\u00a0LJ, Vos\u00a0T, Jensen\u00a0R, Katsarava\u00a0Z (2018) Migraine is first cause of disability in under 50s: will health politicians now take notice? J\u00a0Headache Pain 19(1):17","journal-title":"J Headache Pain"},{"issue":"5","key":"757_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","volume":"19","author":"M Linde","year":"2012","unstructured":"Linde\u00a0M, Gustavsson\u00a0A, Stovner\u00a0LJ, Steiner\u00a0TJ, Barr\u00e9\u00a0J, Katsarava\u00a0Z et\u00a0al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19(5):703\u2013711","journal-title":"Eur J Neurol"},{"issue":"1","key":"757_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders. Cephalalgia 38(1):1\u2013211","journal-title":"Cephalalgia"},{"issue":"3","key":"757_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00482-007-0540-9","volume":"21","author":"A Heinze","year":"2007","unstructured":"Heinze\u00a0A, Heinze-Kuhn\u00a0K, G\u00f6bel\u00a0H (2007) Classification of headache disorders. Schmerz 21(3):263\u2013273 (quiz 74)","journal-title":"Schmerz"},{"key":"757_CR6","unstructured":"Diener H, Gaul C, Kropp P (2018) Therapie der Migr\u00e4neattacke und Prophylaxe der Migr\u00e4ne, S1-Leitlinie. in: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg.), Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. www.dgn.org\/leitlinien. Zugegriffen: 15. Jan. 2020"},{"issue":"6","key":"757_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00482-006-0502-7","volume":"20","author":"H G\u00f6bel","year":"2006","unstructured":"G\u00f6bel\u00a0H, Heinze\u00a0A, Heinze-Kuhn\u00a0K (2006) Prophylactic measures and acute treatment of migraine. Schmerz 20(6):541\u2013554 (quiz 55\u20136)","journal-title":"Schmerz"},{"issue":"2","key":"757_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00482-014-1393-7","volume":"28","author":"H G\u00f6bel","year":"2014","unstructured":"G\u00f6bel\u00a0H, Heinze-Kuhn\u00a0K, Petersen\u00a0I, G\u00f6bel\u00a0C, G\u00f6bel\u00a0A, Heinze\u00a0A (2014) Classification and therapy of medication-overuse headache: impact of the third edition of the International Classification of Headache Disorders. Schmerz 28(2):191\u2013204 (quiz 5\u20136)","journal-title":"Schmerz"},{"issue":"1","key":"757_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00482-009-0858-6","volume":"24","author":"A Heinze","year":"2010","unstructured":"Heinze\u00a0A, Heinze-Kuhn\u00a0K, G\u00f6bel\u00a0H (2010) Preventive medication in migraine headache: individualized clinical pathways. Schmerz 24(1):73\u201379 (quiz 80)","journal-title":"Schmerz"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00757-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-020-00757-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-020-00757-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T13:38:20Z","timestamp":1613741900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-020-00757-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s00108-020-00757-5","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"18 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0G\u00f6bel: Wissenschaftliche Beratung, Vortr\u00e4ge oder Durchf\u00fchrung wissenschaftlicher Studien f\u00fcr Allergan, Almirall Prodesfarma, AstraZeneca, Bayer Vital, Berlin-Chemie, Bionorica, Bristol-Myers Squibb, Fujisawa, GlaxoSmithKline, Gr\u00fcnenthal, Hermal, Ipsen Pharma, Janssen-Cilag, Johnson & Johnson, Krewel Meuselbach, Lichtwer, Menarini Pharma, Merz Pharmaceuticals, Minster Pharmaceuticals, MSD, Novartis, Pfizer, Pharmacia, Sandoz, Schaper & Br\u00fcmmer, Schwarz Pharma, Weber & Weber und SmithKline Beecham. A.\u00a0Heinze: Finanzielle Interessen: Referentenhonorare, Honorare f\u00fcr Beratert\u00e4tigkeit und\/oder Kostenerstattung als passiver Teilnehmer von Allergan, Almirall, Eli Lilly, Gr\u00fcnenthal, Hormosan Pharma, Novartis, TEVA. K.\u00a0Heinze-Kuhn: Finanzielle Interessen: Referentenhonorare und\/oder Kostenerstattung als passiver Teilnehmer von Eli Lilly, Novartis, TEVA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}